Investigation of the effect of catechol-o-methyltransferase gene rs4680 polymorphism on trigeminal neuralgia susceptibility


Abstract views: 173 / PDF downloads: 4

Authors

DOI:

https://doi.org/10.62063/ecb-36

Keywords:

catechol-o-methyltransferase, polymorphism, trigeminal neuralgia

Abstract

Research has been conducted to explore the genetic basis of trigeminal neuralgia, a persistent pain condition that impacts the trigeminal nerve. COMT is an enzyme responsible for inactivating substances and hormones containing catechol and catecholamines. Previous research has linked COMT gene polymorphism with various pain conditions, including migraine. Our research aimed to investigate the correlation between trigeminal neuralgia and the rs4680 polymorphism of the COMT gene. We conducted a research project which included 10 individuals diagnosed with trigeminal neuralgia and 30 healthy individuals as controls. Following collection of blood samples, we isolated DNA from the samples and then genotyping of COMT rs4680 polymorphism was performed with Real-Time PCR, using TaqMan SNP Genotyping Assay. Among the trigeminal neuralgia patients, 2 of them exhibited the AA genotype, 6 had the AG genotype, and 2 had the GG genotype for COMT rs4680. The AG genotype was notably prevalent. No statistically significant differences in the distributions of COMT genotypes and allele frequencies were found between the experimental (patients) and the control group. However, the AG genotype appeared to be more frequent in the patient group. Moving forward, we plan to expand our study by increasing the number of patients and control subjects. This will enable us to further elucidate the potential relationship between COMT gene polymorphism and trigeminal neuralgia.

References

Ahlers, S. J., Elens, L. L., Van Gulik, L., Van Schaik, R. H., Van Dongen, E. P., Bruins, P., Tibboel, D., & Knibbe, C. A. (2013). The Val158Met polymorphism of the COMT gene is associated with increased pain sensitivity in morphine-treated patients undergoing a painful procedure after cardiac surgery. British Journal of Clinical Pharmacology, 75(6), 1506–1515. https://doi.org/10.1111/bcp.12052.

Axelrod, J., & Tomchick, R. (1958). Enzymatic O-methylation of epinephrine and other catechols. Journal of Biological Chemistry, 233, 702-705. https://doi.org/10.1016/S0021-9258(18)64731-3.

Barbosa, F. R., Matsuda, J. B., Mazucato, M., De Castro França, S., Zingaretti, S. M., Da Silva, L. M., Martinez-Rossi, N. M., Júnior, M. F., Marins, M., & Fachin, A. L. (2012). Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromyalgia patients. Rheumatology International, 32, 427–430. https://doi.org/10.1007/s00296-010-1659-z.

Brancher, J. A., Bertoli, F. M. D. P., Michels, B., Lopes-Faturri, A., Pizzatto, E., Losso, E. M., & Wambier, L. M. (2021). Is catechol-O-methyltransferase gene associated with temporomandibular disorders? A systematic review and meta-analysis. International Journal of Paediatric Dentistry, 31(1), 152-163. https://doi.org/10.1111/ipd.12721.

Cohen, H., Neumann, L., Glazer, Y., Ebstein, R. P., & Buskila, D. (2009). The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158)met and fibromyalgia. Clinical and Experimental Rheumatology, 27(5 Suppl 56), 51–56. PMID: 20074440.

Costa, G. M. F., Rocha, L. P. C., Siqueira, S., Moreira, P. R., & Almeida-Leite, C. M. (2019). No association of polymorphisms in Nav1.7 or nerve growth factor receptor genes with trigeminal neuralgia. Pain Medicine, 20, 1362–1369. https://doi.org/10.1093/pm/pny191

Cui, W., Yu, X., & Zhang, H. (2014). The serotonin transporter gene polymorphism is associated with the susceptibility and the pain severity in idiopathic trigeminal neuralgia patients. The journal of headache and pain, 15, 1-6. https://doi.org/10.1186/1129-2377-15-42

Dai, F., Belfer, I., Schwartz, C. E., Banco, R., Martha, J. F., Tighioughart, H., Tromanhauser, S. G., Jenis, L. G., & Kim, D. H. (2010). Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. The Spine Journal, 10(11), 949-957. https://doi.org/10.1016/j.spinee.2010.07.387.

Daniels, J. K., Williams, N. M., Williams, J., Jones, L. A., Cardno, A. G., Murphy, K. C., Spurlock, G., Riley, B., Scambler, P., Asherson, P., McGuffin, P., & Owen, M. J. (1996). No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. American Journal of Psychiatry, 153(2), 268-270. https://doi.org/10.1176/ajp.153.2.268.

Dharaniprasad, G., Samantaray, A., Srikanth, L., Hanumantha, R. M., Chandra, A., & Sarma, P. V. G. K. (2000). Chronic persistent surgical pain is strongly associated with COMT alleles in patients undergoing cardiac surgery with median sternotomy. General Thoracic and Cardiovascular Surgery, 68(10), 1101-1112. https://doi.org/10.1007/s11748-020-01321-6.

Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 98(12), 6917-6922. https://doi.org/10.1073/pnas.111134598.

Emin, E. M., Herken, H., Yilmaz, M., & Bayazit, Y. A. (2001). Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Research Molecular Brain Research, 94, 193–196. https://doi.org/10.1016/S0169-328X(01)00219-4.

Fernandez-de-Las-Penas, C., Ambite-Quesada, S., Gil-Crujera, A., Cigaran-Mendez, M., & Penacoba-Puente, C. (2012). Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome. The Journal of Pain, 13(11), 1068–1074. https://doi.org/10.1016/j.jpain.2012.08.001.

Finan, P. H., Zautra, A. J., Davis, M. C., Lemery-Chalfant, K., Covault, J., & Tennen, H. (2011). COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain, 152, 300–307. https://doi.org/10.1016/j.pain.2010.10.024.

Finan, P. H., Zautra, A. J., Davis, M. C., Lemery-Chalfant, K., Covault, J., & Tennen, H. (2010). Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychology, 29, 134–142. https://doi.org/10.1037/a0018647

Gambeta, E., Gandini, M. A., Souza, I. A., Ferron, L., & Zamponi, G. W. (2021). A CACNA1A variant associated with trigeminal neuralgia alters the gating of Cav2. 1 channels. Molecular Brain, 14, 1-6. https://doi.org/10.1186/s13041-020-00725-y

George, S. Z., Wallace, M. R., Wright, T. W., Moser, M. W., Greenfield, W. H. 3rd, Sack, B. K., Herbstman, D. M., & Fillingim, R. B. (2008). Evidence for a biopsychosocial influence on shoulder pain: pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain ratings. Pain, 136(1-2), 53-61. https://doi.org/10.1016/j.pain.2007.06.019.

Gürsoy, S., Erdal, E., Herken, H., Madenci, E., Alasehirli, B., & Erdal, N. (2003). Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatology International, 23, 104–107. https://doi.org/10.1007/s00296-002-0260-5.

Hagen, K., Pettersen, E., Stovner, L. J., Skorpen, F., & Zwart, J. A. (2006). The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene: the HUNT study. The Journal of Headache and Pain, 7, 70–74. https://doi.org/10.1007/s10194-006-0281-7.

Karling, P., Danielsson, Å., Wikgren, M., Söderström, I., Del-Favero, J., Adolfsson, R., & Norrback, K. F. (2001). The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One, 6(3), e18035. https://doi.org/10.1371/journal.pone.0018035.

Kazanci, D., Polat, T., Doğan, C. S., Aslan, B. T., Oktay, Ş., Bilici, M. F., ... & Ulucan, K. (2021). The determination of IL-6 rs1800795 polymorphism distribution in Turkish national cross-country skiing athletes sub-groups created referring to the 1km CCSTAs. Clinical and Experimental Health Sciences, 11(4), 782-786. https://doi.org/10.33808/clinexphealthsci.904524.

Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., & Weinshilboum, R. M. (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6(3), 243–250. https://doi.org/10.1097/00008571-199606000-00007.

Mannerak, M. A., Lashkarivand, A., & Eide, P. K. (2021). Trigeminal neuralgia and genetics: A systematic review. Molecular Pain, 17, 1-22. https://doi.org/10.1177/17448069211016139.

Meloto, C. B., Segall, S. K., Smith, S., Parisien, M., Shabalina, S. A., Rizzatti-Barbosa, C. M., & Slade, G. D. (2015). COMT gene locus: new functional variants. Pain, 156(10), 2072. https://doi.org/10.1097/j.pain.0000000000000273.

Merskey, H., & Bogduk, N. (1994). Classification of Chronic Pain. IASP Task Force on Taxonomy. 2nd ed. Seattle: IASP Press.

Murphy, D. L., & Wyatt, R. J. (1975). Neurotransmitter-related enzymes in the major psychiatric disorders: I. catechol-O-methyl-transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities. Research Publications - Association for Research in Nervous and Mental Disease, 54, 277-288. PMID: 769115.

Nackley, A. G., Tan, K. S., Fecho, K., Flood, P., Diatchenko, L., & Maixner, W. (2007). Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptors. Pain, 128, 198–208. https://doi.org/10.1016/j.pain.2006.09.022.

Panchagnula, S., Agata, K. S., & Kristopher, T. K. (2019). Familial trigeminal neuralgia cases implicate genetic factors in disease pathogenesis. JAMA Neurology, 76(1), 9-10. https://doi.org/10.1001/jamaneurol.2018.3322.

Park, J. W., Lee, K. S., Kim, J. S., & Kim, Y. I., & Shin, H. E. (2007). Genetic contribution of catechol-O-methyltransferase polymorphism in patients with migraine without aura. Journal of Clinical Neurology, 3, 24–30. https://doi.org/10.3988/jcn.2007.3.1.24.

Pavel, S. (1993). Dynamics of melanogenesis intermediates. Journal of Investigative Dermatology, 100, 162-165. https://doi.org/10.1038/jid.1993.70.

Romero, J., Costa, G. M. F., Rocha, L. P. C., Siqueira, S., Moreira, P. R., & Almeida-Leite, C. M. (2021). Polymorphisms of Nav1.6 sodium channel, brain-derived neurotrophic factor, catechol-O-methyltransferase, and guanosine triphosphate cyclohydrolase 1 genes in trigeminal neuralgia. Clinical Neurology and Neurosurgery, 208, 106880. https://doi.org/10.1016/j.clineuro.2021.106880.

Siqueira, S. R. D. T. D., Alves, B., Malpartida, H. M. G., Teixeira, M. J., & Siqueira, J. T. T. D. (2009). Abnormal expression of voltage-gated sodium channels Nav1. 7, Nav1. 3 and Nav1. 8 in trigeminal neuralgia. Neuroscience, 164(2), 573-577. https://doi.org/10.1016/j.neuroscience.2009.08.037

Taerk, E., Grizenko, N., Ben Amor, L., Lageix, P., Mbekou, V., Deguzman, R., Torkaman-Zehi, A., Ter Stepanian, M., Baron, C., & Joober, R. (2004). Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Medical Genetics, 5, 30. https://doi.org/10.1186/1471-2350-5-30.

Tanaka, B. S., Zhao, P., Dib-Hajj, F. B., Morisset, V., Tate, S., Waxman, S. G., & Dib-Hajj, S. D. (2016). A gain-of-function mutation in Nav1. 6 in a case of trigeminal neuralgia. Molecular medicine, 22, 338-348. https://doi.org/10.2119/molmed.2016.00131

Van Meurs, J. B., Uitterlinden, A. G., Stolk, L., Kerkhof, H. J., Hofman, A., Pols, H. A., & Bierma-Zeinstra, S. M. (2009). A functional polymorphism in the catechol-O-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis & Rheumatology, 60(2), 628–629. https://doi.org/10.1002/art.24175.

Voelker, P., Sheese, B. E., Rothbart, M. K., & Posner, M. I. (2009). Variations in catechol-O-methyltransferase gene interact with parenting to influence attention in early development. Neuroscience, 164(1), 121–130. https://doi.org/10.1016/j.neuroscience.2009.05.059.

Zakrzewska, J. M. (2002). Diagnosis and differential diagnosis of trigeminal neuralgia. The Clinical Journal of Pain, 18, 14-21. https://doi.org/10.1097/00002508-200201000-00003.

Zubieta, J. K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., Koeppe, R. A., Stohler, C. S., & Goldman, D. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 299(5610), 1240–1243. https://doi.org/10.1126/science.1078546.

Downloads

Published

2025-01-20

How to Cite

Akarsu, N., Yilmaz, O. O., Tacal Aslan, B., Gungor, F., Gulluoglu, M., Dergin, G., & Ulucan, K. (2025). Investigation of the effect of catechol-o-methyltransferase gene rs4680 polymorphism on trigeminal neuralgia susceptibility. The European Chemistry and Biotechnology Journal, (3), 1–10. https://doi.org/10.62063/ecb-36

Issue

Section

Research Articles